Sign In
Buy CLOV
$3.65
-0.0800 (-2.14%)
At Close: Jun 03, 2026
Clover Health: Watch Out For Volatility Following Q4 Earnings Results
10:35am, Tuesday, 11'th Feb 2025
I remain bullish on Clover Health long-term but prefer to Hold until Q4 2024 earnings for higher conviction before initiating a long position in this stock. I believe the 40% YTD rise and 60% retail o
Clover Health Investments Is Building A Competitive Moat
03:42am, Tuesday, 21'st Jan 2025
Clover Health Investments, Corp. is a healthcare provider focused on providing Medicare Advantage plans to seniors. The company's proprietary AI technology helps drive higher reimbursement rates and l
Clover Health: Undervalued Turnaround Play With Promising SaaS Potential
11:24am, Thursday, 16'th Jan 2025
Clover Health's revenue rose 8% in Q3 2024, driven by a 7% growth in Medicare Advantage premiums, despite exiting low-margin ACO REACH program. Cost control measures are paying off, with salaries and
Focus On Costs, Regulatory Outlook For Health Insurers In Q4'24 Earnings Season
10:50am, Thursday, 16'th Jan 2025
Most publicly traded US health insurers are forecast to report sequential revenue and earnings declines for the fourth quarter of 2024, according to S&P Global Market Intelligence analysis of sell-sid
Clover Health Reports 27% Growth in Medicare Advantage Membership, Surpassing 100,000 Lives After Strong Annual Election Period
09:00am, Monday, 13'th Jan 2025
WILMINGTON, Del., Jan. 13, 2025 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (Nasdaq: CLOV) (“Clover,” “Clover Health” or the “Company”), today announced a 27% year-over-year growt
Counterpart Health Deploys Counterpart Assistant with Leading Accountable Care Organization
09:00am, Tuesday, 07'th Jan 2025
WILLMINGTON, Del., Jan. 07, 2025 (GLOBE NEWSWIRE) -- Counterpart Health, Inc. (“Counterpart”), an AI-powered physician enablement platform, today announced it has successfully deployed its Counter
4 MedTech Stocks That Gained More Than 100% in 2024 With Room to Run
11:56am, Monday, 23'rd Dec 2024
Here are some strong MedTech stocks - DOCS, CLOV, CLPT and HIMS - that are expected to provide promising gains.
Recent Earnings Disappointment Could Be An Ideal Buying Opportunity For Clover Health
02:35am, Saturday, 21'st Dec 2024
Clover Health's recent performance shows mixed results, with revenue growth but a significant share price drop, presenting a potential buying opportunity. Operational efficiency is improving, with bet
Clover Health to Participate in Upcoming 43rd Annual J.P. Morgan Healthcare Conference
04:05pm, Tuesday, 17'th Dec 2024
JERSEY CITY, N.J., Dec. 17, 2024 (GLOBE NEWSWIRE) -- Remote-First Company -- Clover Health Investments, Corp. (Nasdaq: CLOV) (“Clover,” “Clover Health” or the “Company”), today announced t
Clover Health: Balancing Innovation And Challenges
07:19am, Wednesday, 11'th Dec 2024
Clover Health Investments shows financial progress and challenges in 2024, with a focus on innovative Medicare Advantage plans and technology-driven healthcare solutions. The company achieved a 4.0 ra
Here's Why Clover Health Investments (CLOV) Could be Great Choice for a Bottom Fisher
10:55am, Thursday, 05'th Dec 2024
After losing some value lately, a hammer chart pattern has been formed for Clover Health Investments (CLOV), indicating that the stock has found support. This, combined with an upward trend in earning
5 Medical Info System Stocks to Buy for a Stable Portfolio in 2025
09:01am, Wednesday, 04'th Dec 2024
Five medical info systems stocks have strong potential for 2025. These are: INSP, OMCL, TALK, BFLY, CLOV.
Clover Health: Buy The Dip, Reap The Rewards
11:50am, Monday, 18'th Nov 2024
Clover's 32% dip following its Q3 earnings could be an opportunity to accumulate shares. Clover continues to grow its topline and improve its bottom line performance. Clover's latest star rating upgra
Down -26.32% in 4 Weeks, Here's Why Clover Health Investments (CLOV) Looks Ripe for a Turnaround
10:36am, Friday, 15'th Nov 2024
Clover Health Investments (CLOV) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street anal
Down -25.82% in 4 Weeks, Here's Why Clover Health Investments (CLOV) Looks Ripe for a Turnaround
10:35am, Thursday, 14'th Nov 2024
The heavy selling pressure might have exhausted for Clover Health Investments (CLOV) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall
